Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Reneo Pharmaceuticals Inc (RPHM)

Reneo Pharmaceuticals Inc (RPHM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Shortened Week Due to Easter Holiday Baystreet - Fri Mar 22, 3:46PM CDT

Monday U.S. Economic Lookahead New home sales (Feb.) Featured Earnings PVH Corp. (NYSE: ...

NOVC.TO : 1.29 (+1.57%)
ANRG.TO : 0.2950 (+1.72%)
AEZS.TO : 11.09 (+3.64%)
PVH : 114.01 (-1.20%)
RPHM : 1.8100 (-2.69%)
MKC : 76.15 (+1.08%)
GME : 17.46 (-3.05%)
PRGS : 50.95 (+0.26%)
CTAS : 700.27 (+0.58%)
PAYX : 122.55 (+1.03%)
CCL : 14.43 (-0.89%)
WBA : 17.19 (-0.35%)
Reneo Pharmaceuticals Reports Second Quarter 2022 Financial Results Globe Newswire - Tue Aug 9, 2022

IRVINE, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Appoints Roshawn Blunt to its Board of Directors Globe Newswire - Tue Aug 2, 2022

IRVINE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates Globe Newswire - Tue Jul 26, 2022

LC-FAOD program to move forward into the next stage of clinical developmentEnrollment of pivotal STRIDE study in primary mitochondrial myopathies (PMM)...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Mon Jul 11, 2022

IRVINE, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Reports First Quarter 2022 Financial Results Globe Newswire - Tue May 10, 2022

IRVINE, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update Globe Newswire - Wed Mar 23, 2022

IRVINE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Announces Senior Leadership Promotions Globe Newswire - Mon Mar 7, 2022

Michael P. Cruse appointed Chief Operating OfficerJennifer P. Lam appointed Principal Financial and Accounting Officer IRVINE, Calif., March 07, 2022 ...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals Enters Oversold Territory (RPHM) Dividend Channel - Tue Feb 8, 2022

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

RPHM : 1.8100 (-2.69%)
Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference Globe Newswire - Wed Feb 2, 2022

IRVINE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the...

RPHM : 1.8100 (-2.69%)

Barchart Exclusives

3 Reasons This Mega-Cap Stock Will Continue to Soar in 2024 and Beyond Barchart - Sat May 11, 2:45PM CDT
Despite the stiff competition, Wall Street believes Netflix will continue to rule the streaming space. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot